Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vosaroxin
vosaroxin
Is This the End of Sunesis?
24/7 Wall St
Fri, 07/24/15 - 06:00 pm
Sunesis
FDA
AML
vosaroxin
acute myeloid leukemia
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Motley Fool
Thu, 04/10/14 - 11:13 pm
Merrimack Pharmaceuticals
Sunesis
pancreatic cancer
MM-398
vosaroxin
3 Small Cap Biotechs Developing Novel Cancer Treatments
Motley Fool
Wed, 02/19/14 - 12:56 pm
Inovio
VGX-3100
Cervical Intraepithelial Neoplasia
MM-398
Merrimack Pharmaceuticals
acute myeloid leukemia
vosaroxin
Sunesis
An ASCO Bio-Pharma Catalyst Trade With A Promising Leukemia Drug
Seeking Alpha
Wed, 05/9/12 - 10:19 am
leukemia
ASCO
Sunesis
Bristol-Myers Squibb
vosaroxin
Ariad Pharmaceuticals
Sanofi
AML
Novartis
Sunesis tumbles 16% in early trading
Marketwatch
Mon, 06/6/11 - 11:08 am
Sunesis
vosaroxin
acute myeloid leukemia
Sunesis Signs Deal, Improves Pipeline Prospects
Seeking Alpha
Sat, 04/9/11 - 11:07 am
Sunesis
vosaroxin
pan-Raf kinase inhibitors